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Kampala Cancer Registry was established in 1954 with the aim of
obtaining information on cancer occurrence in the population of
Kyadondo County in which the capital city of Kampala is situated
(Davies et al, 1965). The registry is located in the Department of
Pathology in Makerere University Medical School. It functioned
continuously both pre- and post-independence (1962), until the
coup d’état of General Amin Dada in 1971. Thereafter, full popu-
lation coverage was not possible, although a register was main-
tained within the Pathology Department until 1980, when all
registration ceased. With the return of political stability, the
registry was restarted (in 1989) and has functioned continuously
since. This long period of operation provides a unique opportunity
to study temporal changes in cancer patterns in an African setting.
Within Kyadondo, there have been quite marked social changes
over the last 40 years. Progressive urbanization of the population
has meant that, although the total population has increased more
than fourfold, Kampala city has grown almost tenfold, from a
population of 92 000 in 1959 to 870 000 in 1995, and now repre-
sents three-quarters of the county population. There has also been
an increase in educational standards: the population of 10 years
and above who have ever been to school increased among males
from 4.7% in 1959 to 71.8% in 1991 and among females from
1.8% to 61.9%. In addition, Uganda is one of the countries most
affected by the HIV epidemic, and therefore temporal changes
reveal its effect on cancer occurrence in Africans.
Previous incidence rates for Kyadondo County have been
published for the periods 1954–1960 (Davies et al, 1962, 1965)
and 1968–1970 (Templeton et al, 1972). In addition, a comprehen-
sive descriptive analysis for the period 1964–1968, based on all
registrations (not restricted to Kyadondo residents, and without
calculation of incidence rates), was published as a monograph
(Templeton, 1973). The first results from the revitalized registry
for a 28-month period in 1989–1991 were published in 1993
(Wabinga et al, 1993). Here we review incidence rates for
Kyadondo County for two extended periods, 1960–1971 and
1991–1997, with a focus on the trends in risk of different cancers
both during and between these periods.
MATERIALS AND METHODS
Cancer records
In 1953 the request/result forms of the Department of Pathology
were redesigned specifically to permit registration of cancers.
Thus they contain demographic information on the patient such as
name, age, sex, tribe and place of residence, as well as the source
of the specimen and results of the examination. In addition to data
collected in this way, tumour registrars have been employed to
search for cancer cases admitted to, or treated in, the four main
hospitals in Kampala (and more recently in the Uganda Hospice)
and, for individuals resident in Kyadondo County, to extract some-
what more extensive information onto special notification forms.
Between 1954 and 1980, registration was manual apart from the
period 1964–1968 when the data were transferred to punchcards
(Templeton, 1973), which are no longer available, with details of
all cancer cases identified being entered in a large ‘register’. Since
1989 the registration process has been computerized, using the
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prevents the use of non-existent codes and performs checks for
internal consistency between variables. It also permits a search for
potential duplicate registrations.
The records from the registers of 1960–1980 have also been
entered into the CANREG system (the registers for 1954–1959 were
no longer available, and had probably been removed from the
country). Several duplicate entries were identified, as well as a
considerable number of errors and missing information. Doubtful
records were completed, corrected or deleted, after tracing the
original archives in the records of the hospitals and the pathology
department.
Tumour site and morphology were coded according to the
second edition of the International Classification of Diseases for
Oncology (Percy et al, 1990). For tabulation of results, these were
converted to the 10th revision of the ICD (WHO, 1992) and to the
International Classification for Childhood Cancer (Kramárová
et al, 1997).
Since registration ceased to be population-based between 1972
and 1980, the data for this period were not used in the current
analyses. With the availability of 8 full years’ registration since the
restart of the registry in late 1989, it was clear that the case finding
for 1990 was inadequate and so the data for this year, included
in a previous publication (Wabinga et al, 1993) were excluded.
Otherwise, inspection of the annual number of registrations (and
proportions of registrations based on histological examinations)
showed a regular progression with time. We therefore chose to
consider four time periods: 1960–1966 (7 years); 1967–1971
(5 years), 1991–1994 (4 years); 1995–1997 (3 years).
Population data
Population censuses were performed in 1959, 1969 and 1991. For
these years, the population of Kyadondo County was available by
sex and 5-year age group. An estimate for 1995 was provided
by the Department of Statistics of the Ministry of Finance and
Economic Planning; this was a simple extrapolation of the 1991
result, assuming an annual growth in each age group of 2.61% for
males and 2.30% for females. An interpolation between the census
of 1959 and 1969 was prepared, assuming a constant rate of
increase within age/sex groups, and projections for 1996 and 1997
were made, assuming the same growth rate as that provided for
1991–1995.
For the calculation of incidence rates in the four periods consid-
ered, we used: the estimated population for 1963, the census
population of 1969 and the estimated average populations for
1991–1994 and 1995–1997. These are shown in Table 1.
Statistical methods
Incidence rates for each of the four periods were calculated for
5-year age groups. Age-standardized rates (world standard popula-
tion) and 95% confidence limits were calculated as described in
Boyle and Parkin (1991). Differences between rates were tested by
means of the Mantel–Haenzel test, stratifying for age in 5-year
groups (Estève et al, 1994).
RESULTS
During the 19 years of registration considered (1960–1971;
1991–1997) a total of 7312 cases (3576 male and 3736 female)
were registered. Tables 2 and 3 show, for males and females
respectively, the number of cases in each of the four time periods,
by major cancer sites, together with the age-standardized inci-
dence rates, and their standard errors. The statistical significance
of the change in the incidence rate from the preceding period is
shown.
In both sexes, the total incidence of cancer (all sites combined)
increased across the four periods. The most dramatic increase
between the decades of the 1960s and the 1990s is in the incidence
of Kaposi’s sarcoma (KS), especially for females, in whom KS
was previously a rather rare disease (sex ratio almost 20:1) but in
whom the incidence rate is now around half that of men. Figure 1
shows age-specific incidence rates for KS, for 1960–1971 and
1991–1997 in men and, for the latter period only, in women. In
males, as well as the increase in incidence, the shape of the curve
has changed: in the 1960s there was a progressive increase in risk
with age, while in the 1990s there is a small peak in incidence in
childhood, and a more marked one in the late 30s. In females, inci-
dence in childhood is lower, and the peak incidence in adults is at
ages 25–29. The mean age at diagnosis in the 1991–1997 period is
significantly later (P < 0.001) in men than in women both for all
cases (32.0 vs 27.1), and for cases in adults aged 15 or more
(34.9 vs 29.8).
Other than KS, the cancers showing the most marked increases
in incidence in males are cancers of the prostate and oesophagus.
There have also been significant increases in rates for cancers of
the large bowel and eye and, in the last 3 years, of non-Hodgkin
lymphoma. Although the changes in incidence between the indi-
vidual time periods are not statistically significant, the trends in
incidence rates between 1960–1966 and 1995–1997 are highly
significant (P < 0.01) for both stomach and lung cancers.
Conversely, there have been significant decreases in the incidence
rates of cancers of the bladder and penis, and of Hodgkin’s disease
and leukaemia. Liver cancer, which was the most common cancer
of men in the 1960s, appears to have declined in incidence during
the 1990s.
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Table 1 Average annual population at risk, Kyadondo County, Uganda, and percentage by age group and sex
1960–1966 1967–1971 1991–1994 1995–1997
MFMFMFM F
0–14 30.8 39.0 34.3 43.5 40.6 43.5 40.6 43.5
15–44 57.9 50.9 55.8 47.6 52.4 50.0 52.4 50.0
45–55 5.9 4.8 5.1 4.2 4.0 3.2 4.0 3.2
55–64 2.9 2.8 2.5 2.2 1.6 1.7 1.6 1.7
65+ 2.3 2.4 2.2 2.4 1.3 1.7 1.3 1.7
Total 152 000 116 500 225 400 185 400 526 900 546 600 577 200 592 400In females, the increasing trends for cancers of the oesophagus,
stomach, large bowel, eye and non-Hodgkin lymphomas are
similar to those in men, and there have also been increases in
incidence of the two major cancers of women – breast cancer and
cervix cancer. Figure 2 shows age-specific incidence rates of
cervix cancer in the four different periods. The progressive
increase of incidence with age in the earlier periods is replaced in
the 1990s by a pattern of peak incidence around menopause,
followed by a plateau. Nevertheless, there has been no significant
alteration in the mean age at diagnosis between the four time
periods (43.8, 42.8, 43.2 and 43.7).
The decline in bladder cancer incidence between the 1960s and
1990s has concerned almost exclusively squamous cell carci-
nomas (SCCs). In 1960–1971, 28/48 (58%) of histologically
confirmed bladder cancer cases were SCCs, and just 10/48 (21%)
transitional cell/adenocarcinomas. In 1991–1997 the percentages
were 19% (3/16) SCC and 56% (9/16) transitional cell carcinomas.
Incidence rates of oesophageal cancer are similar in the two
sexes, which is unusual for this tumour, even in the African conti-
nent. Forty-one per cent of the oesophageal cancers had informa-
tion on histological subtypes. All were carcinomas, with 87.1%
squamous, 7.1% adenocarcinomas and 5.7% unspecified subtype;
there was no evidence of a change in the proportions over time.
The large increase in incidence of eye cancers is the conse-
quence of increasing incidence of SCCs of conjunctiva. These
increased from 4/17 eye cancers (23.5%) in men in 1960–1971
Trends in cancer incidence in Kyadondo, Uganda 1587
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Figure 1 Age-specific incidence rates of Kaposi’s sarcoma
Table 2 Incidence of the major cancers in Kyadondo County, Uganda, in four time periods: males
1960–1966 1967–1971 1991–1994 1995–1997
No. ASR (standard No. ASR (standard  No. ASR (standard  No. ASR (standard 
error) error) error) error)
Nasopharynx 3 0.3 (0.2) 9 1.8 (0.7) 11 0.7 (0.2) 26 2.3 (0.6)b
Oesophagus 8 1.7 (0.6) 25 5.1 (1.1)c 83 15.8 (1.9)c 68 13.0 (1.8)
Stomach 14 2.7 (0.8) 20 4.7 (1.1) 31 4.7 (1.0) 37 7.6 (1.4)
Colon & rectum 14 3.0 (0.8) 23 4.8 (1.1) 52 8.3 (1.3)a 38 6.8 (1.4)
Liver 44 6.0 (1.1) 75 11.7 (1.6)c 73 9.8 (1.4)d 41 5.9 (1.2)d
Lung 5 0.8 (0.4) 10 2.1 (0.8) 25 4.1 (1.0) 19 3.2 (1.0)
Melanoma 1 0.1 (0.1) 8 1.3 (0.6)a 7 1.5 (0.7) 7 1.1 (0.5)
Skin 26 3.7 (0.8) 27 4.3 (0.9) 18 2.5 (0.7)e 20 4.1 (1.0)
Kaposi’s sarcoma 28 3.2 (0.7) 29 3.7 (0.8) 670 39.3 (2.1)c 513 39.3 (2.3)
Prostate 13 3.1 (0.9) 27 6.8 (1.4)a 113 26.3 (2.6)c 139 39.2 (3.7)a
Penis 29 5.5 (1.1) 30 6.3 (1.2) 18 2.9 (0.8)e 23 4.4 (1.1)
Bladder 24 5.2 (1.1) 27 5.9 (1.2) 13 2.5 (0.8)f 10 2.9 (0.9)
Eye 5 0.4 (0.2) 12 1.1 (0.4) 43 2.3 (0.4)a 47 3.0 (0.6)
Hodgkin’s disease 16 1.9 (0.6) 17 1.7 (0.5) 8 0.8 (0.4)f 11 1.3 (0.6)
NHL 32 3.9 (0.8) 32 3.6 (0.7) 76 3.6 (0.5) 95 7.4 (1.1)b
Leukaemia 22 2.2 (0.6) 24 3.2 (0.9) 13 0.7 (0.2)f 16 1.1 (0.3)
ALL 352 54.2 (3.3) 478 81.2 (4.3) 1456 149.1 (5.2) 1290 166.6 (6.2)
ALL (except KS) 324 51.0 449 77.5 780 109.8 777 127.3
Significant increase since preceding period: aP < 0.05; bP < 0.01; cP < 0.001.Significant decrease since preceding period: dP < 0.05; eP < 0.05; fP < 0.001.(none of the seven eye cancers in women), to 32/45 (71% in men)
and 34/40 (85%) in women in the most recent 3-year period (there
were a few cases of unknown histological type).
Table 4 shows incidence rates for certain cancers of childhood
(ages 0–14) in two periods, 1960–1971 and 1991–1997. The most
striking change is the increased incidence of KS, from 2.5 per
million in 1960–1971, to 55.1 per million in 1991–1997. The male
predominance has persisted (sex ratio 1.5:1), and KS has become
the most common tumour of childhood, ahead of the lymphomas.
The mean age of these cases was 5.0, with no difference between
the sexes, incidence was slightly higher in the age group 5–9 than
at 0–4 (Figure 4). Lymphomas remain relatively frequent, with
Burkitt’s lymphoma (BL) by far the most frequently diagnosed in
1991–1997; the peak age is at 5–9 (Figure 3) with a mean age of
6.6, and boys predominate with a ratio of 1.4:1. The incidence of
BL was significantly higher (P < 0.001) in the 1990s than in the
1960s. This is unlikely to be due to changing classification or
coding, since the incidence of other and unspecified non-Hodgkin
lymphomas was also higher in the second period (Table 4). In
contrast, the incidence of childhood leukaemia is low, and there
was a significant (P < 0.05) fall in incidence between the two
periods.
DISCUSSION
In order to study time trends, it is important that the degree of
completeness of registration of incident cancer cases should be
similar throughout the period under consideration. In recent years
(since 1991) we believe that registration has been relatively good;
an exercise in independent case ascertainment (Parkin et al, 1994),
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Table 3 Incidence of the major cancers in Kyadondo County, Uganda, in four time periods: females
1960–1966 1967–1971 1991–1994 1995–1997
No. ASR (standard No. ASR (standard No. ASR (standard No. ASR (standard
error) error) error) error)
Nasopharynx 3 0.7 (0.4) 2 0.3 (0.2) 13 0.9 (0.3) 21 1.6 (0.4)a
Oesophagus 9 2.6 (0.9) 31 7.9 (1.5)c 55 9.4 (1.3) 63 14.2 (1.9)a
Stomach 4 0.8 (0.5) 14 3.4 (1.0)a 22 3.2 (0.7) 28 5.6 (1.1)
Colon & rectum 11 2.7 (0.9) 22 6.3 (1.5)a 36 5.7 (1.1) 34 6.6 (1.2)
Liver 9 1.8 (0.6) 21 5.0 (1.3) 42 5.1 (1.0) 35 6.3 (1.3)
Lung 3 0.6 (0.4) 6 1.4 (0.6) 7 0.7 (0.3) 18 3.2 (0.9)b
Melanoma 7 1.8 (0.7) 9 2.5 (0.8) 8 1.3 (0.5) 8 2.2 (0.8)
Skin 16 4.0 (1.1) 15 3.1 (0.9) 12 1.4 (0.5)d 8 1.0 (0.4)
Kaposi’s sarcoma 1 0.1 (0.1) 2 0.2 (0.1) 360 17.9 (1.2)c 335 21.8 (1.5)
Breast 52 11.7 (1.8) 45 9.8 (1.6) 161 19.1 (1.8)c 146 22.0 (2.1)
Cervix uteri 84 17.7 (2.2) 109 22.5 (2.5) 341 39.7 (2.5)c 296 44.1 (3.0)
Corpus uteri 14 3.1 (0.9) 18 4.6 (1.3) 30 4.1 (0.9) 21 4.0 (0.9)
Ovary 26 5.7 (1.3) 19 3.2 (0.8) 62 6.9 (1.1) 41 5.3 (1.0)
Vulva/vagina 8 1.8 (0.7) 10 2.1 (0.8) 7 0.6 (0.3) 11 1.6 (0.6)
Eye 4 0.3 (0.2) 3 0.2 (0.1) 37 1.7 (0.4)c 45 3.4 (0.7)a
Thyroid 5 1.3 (0.6) 12 3.0 (1.0) 22 2.6 (0.7) 34 5.6 (1.1)
Hodgkin’s disease 2 0.6 (0.5) 7 0.7 (0.3) 7 0.2 (0.1) 13 0.9 (0.3)
NHL 14 2.2 (0.7) 15 2.2 (0.7) 48 2.1 (0.4) 82 5.7 (0.9)c
Leukaemia 13 2.3 (0.7) 20 2.8 (0.7) 17 1.2 (0.4)f 17 1.9 (0.6)
ALL 338 73.0 (4.4) 469 98.9 (5.3) 1508 146.8 (4.8) 1421 179.7 (6.0)
ALL (except KS) 337 72.9 467 98.7 1148 128.9 1086 157.9
Significant increase since preceding period: aP < 0.05; bP < 0.001; cP < 0.001. Significant decrease since preceding period: dP < 0.05; eP < 0.05; fP < 0.001.
Table 4 Cancer in children (age 0–14), Kyadondo County, 1960–1971 and 1991–1997
1960–1971 1991–1997
n (%) M:F Age standard rate (per 106) n (%) M:F Age standard rate (per 106)
Leukaemia 25 (18.4) 1.1 18.7 27 (4.9) 0.7 8.6
Hodgkin’s disease 11 (8.1) 2.7 8.7 9 (1.6) 1.3 2.8
Burkitt’s lymphoma 13 (9.6) 1.6 9.5 109 (19.7) 1.5 34.3
Other NHLa 18 (13.4) 2.6 13.1 61 (11.1) 1.3 19.1
Brain & CNS 4 (2.9) 0.3 3.0 7 (1.3) 2.5 2.3
Neuroblastoma 5 (3.7) 1.5 2.9 1 (0.2) – 0.3
Retinoblastoma 16 (11.8) 1.7 9.4 33 (6.0) 1.4 9.3
Wilm’s tumour 10 (7.4) 0.7 6.1 29 (5.3) 1.6 8.6
Osteosarcoma 5 (3.7) 1.5 4.2 6 (1.1) 4.0 1.9
Kaposi’s sarcoma 3 (2.2) 2.0 2.5 183 (33.2) 1.5 55.8
Other STS 10 (7.4) 4.0 7.6 20 (3.6) 0.8 6.0
Carcinomas 9 (6.7) 2.0 7.4 18 (3.3) 1.3 5.7
Total 136 (100) 1.6 97.8 552 (100) 1.4 169.7
aIncludes lymphoma (unspecified).comparing data collected for epidemiological studies in Kampala
with the registry database, suggested that the registry had identi-
fied 90% of incident cancers. For the earlier periods, we can be
less certain.
Some indication of completeness of registration is also provided
by the level of histological (or cytological) verification of regis-
tered cancer cases (Parkin et al, 1994). Table 5 shows that histo-
logical verification was considerably more frequent in the earlier
time periods. This may be only a partial reflection of reality;
certainly, before the country was plunged into political, social and
economic chaos in the 1970s the standard of diagnostic (and thera-
peutic) services was higher than in the period of reconstruction in
the early 1990s. But it is also possible that the case-finding mech-
anisms particularly in the first period studied here were less active
than in the 1990s and that some cases without biopsies were
missed. Finally, the wider availability of diagnostic modalities,
such as endoscopy, in the 1990s may have improved case finding
for certain cancers. The results should be interpreted, therefore, in
the light of increases which could be due to better identification of
cases diagnosed without histology. Templeton et al (1972) note
that decreasing incidence rates are likely to be more meaningful
than small increases in apparent incidence which might be related
to improvements in diagnostic facilities.
In addition to these considerations, comparison of incidence
rates requires that accurate population denominators are available.
For Kyadondo, we had available estimates by age group and sex
for three points during the long period studied, and made use of
interpolations and projections for the other years. There must be
some question as to the accuracy of the estimates of person-years
at risk, therefore, particularly with respect to the age distributions,
although no better data are, of course, available.
Davies et al (1964) reviewed hospital records from Mengo
Hospital (in Kyadondo County) from 1897 to 1956. They noted
that the general pattern of malignant diseases admitted to the
hospital changed little over this period. The first estimation of inci-
dence rates from the cancer registry of Kyadondo County was for
1954–1960 (Davies et al, 1962, 1965). The overall incidence
reported for 1954–1960 was a little higher than our result for
1960–1966 (crude rates of 39.5 vs 33.1 for men and 48.4 vs 41.5
for women). It is possible that registration was rather more
complete during the earlier period, when the proportion of cases
registered without histology was 27.5%, compared with 16.4% in
1960–1966. On the other hand, experience with computer checks
on the manual register for 1960–1971 showed that several dupli-
cate registrations and non-malignant cases had been included, and
these may also have inflated the numbers in the earlier time period.
Nevertheless, for the individual cancer sites, the age-standardized
rates are very similar in the two periods.
Incidence rates for the period 1967–1971 were very similar to
those reported for 1968–1970 by Templeton et al (1972) with
crude all-sites rates of 42.5 and 42.4 per 100 000 in men, and 50.2
and 50.6 per 100 000 in women.
Over the 38-year period, the cancers showing the most dramatic
increases in incidence are those related to infection with HIV,
particularly KS, and SCC of the conjunctiva (Beral and Newton,
1998). KS has always been observed in the Ugandan population,
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Figure 2 Age-specific incidence rates of cancer of the cervix uteri
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Figure 3 Age-specific incidence rates for Burkitt’s lymphoma and Kaposi’s
sarcoma of childhood in 1991–1997 (both sexes)
Table 5 Percentage of cases registered with diagnosis based on cytology
or histology (MV%)
Period
Cancer site 1960–1966 1967–1971 1991–1994 1995–1997
Oral cavity and pharynx 91 97 59 84
Oesophagus 65 68 28 41
Stomach 83 74 30 57
Colon and rectum 86 87 58 69
Liver 85 79 33 36
Lung 75 81 41 76
Kaposi’s sarcoma 76 94 78 86
Breast 82 88 56 68
Cervix 74 70 58 64
Prostate 62 67 66 80
Bladder 89 77 45 50
Lymphoma 96 93 72 80
Leukaemia 54 71 43 39
All cancers 84 84 64 73although in the 1950s and 1960s it was of the typical ‘endemic’
pattern, involving the skin, particularly the legs, and affecting
principally males, with the risk rising progressively with age
(Taylor et al, 1971; Templeton, 1981). The enormous increase in
incidence of KS since the earlier periods, together with the
narrowing of the sex-ratio (from 18:1 in 1960–1971 to 1.7:1 in the
1990s) was noted in a previous report (Wabinga et al, 1993), and
Ziegler and Katangole-Mbidde (1996) have drawn attention to the
dramatic increase in the incidence of KS in children. Uganda, in
common with other central African countries, has a very high
prevalence of infection with HIV, and the age-specific incidence of
KS corresponds closely to the age-specific reporting rates for
AIDS, which are highest at ages 30–39 for men and 20–29 for
women (UNAIDS, 1998). The prevalence of HIV infection among
pregnant women had reached 30% in the urban population of
Kampala in 1990–1992 (UNAIDS, 1998), but since that time it has
been reported to be in decline (to around 15% in 1996–1997). This
may explain the relative stability in the incidence of KS in
1995–1997 relative to 1991–1994 observed in this study.
Currently, the evidence suggests that human herpes virus 8
(HHV8) is the aetiological agent responsible for KS (IARC,
1998). HHV8 has been identified in over 85% of KS tissue speci-
mens in Uganda (Chang et al, 1996). Seroprevalence studies
suggest a relatively high prevalence of infection by HHV8 in the
general population of Uganda – considerably higher than in the
USA and Europe, which would be consistent with the elevated
frequency of ‘endemic’ KS which preceded the AIDS epidemic
(Gao et al, 1996; Simpson et al, 1996).
Unlike KS, the incidence of non-Hodgkin lymphomas, which
are found to be particularly common among immunosuppressed
individuals in Europe and USA, had remained relatively stable in
Kyadondo County in the early 1990s (Wabinga et al, 1993).
However, in 1995–1997 there appears to have been a significant
increase in incidence both in males and females. This may relate to
improved survival of patients with HIV infection as other oppor-
tunistic infections are controlled, permitting a more prolonged
duration of immunosuppression, and the development of more
clinically-evident lymphomas.
Squamous cell carcinomas of the conjunctiva have been recog-
nized for many years as more common in Africans than in
Europeans, but there is also a considerable (tenfold or more)
increase in risk in the presence of HIV infection (Newton, 1996).
Ateenyi-Agaba (1995) has reported a large increase in the
numbers of cases presenting clinically in Kampala since the onset
of the AIDS epidemic.
The increase in the incidence of oesophageal cancer between
the 1960s and 1990s, particularly among males, is difficult to
explain. Studies in southern Africa, as elsewhere, have pointed to
the importance of tobacco smoking and, less certainly, alcohol as
being important in aetiology (van Rensburg et al, 1985; Segal et al,
1988; Vizcaino et al, 1995). The sex ratio of oesophageal cancer in
Uganda has always been quite close to one to one, which suggests
that tobacco and alcohol are not of major importance in the rela-
tively high, and increasing, rates, since smoking (in particular) is
largely confined to males. Furthermore, tobacco smoking is not
common (average consumption per adult is 300 manufactured
cigarettes per year), there has been little change between 1970 and
1990 (WHO, 1997), and the incidence of lung cancer has remained
low in both sexes. Consumption of alcoholic beverages, on the
other hand, is quite high (IARC, 1988) and after a decline through
the 1970s to a low point of around 140 calories per caput per day
in 1985, has since been increasing again (FAO, 1998). On the
other hand, the importance of cereal-based diets, particularly those
relying upon maize, has been stressed with respect to the risk in
Africa, and in particular in explaining the marked differences in
risk within quite small geographic areas (Cook, 1971; van
Rensburg, 1981). The mechanism could be via nutritional defi-
ciencies associated with such diets (van Rensburg et al, 1983;
Jaskiewicz, 1989) or contamination of maize with mycotoxins
(Sydenham et al, 1990). However, maize is not the staple food in
Kyadondo area of Uganda, where consumption of a variety of
plantains is the major source of carbohydrate.
The rather higher incidence rates of gastric cancer in the more
recent periods possibly reflects better diagnosis because of the
availability of gastroscopy; however, the incidence of this cancer
remains low. This is certainly not due to a low prevalence of
Helicobacter pylori – recognized by the IARC (1994) as an impor-
tant cause – since the infection has been shown to be common, at
least in the western part of Uganda (Wabinga, 1996). Tumours of
the large bowel are also rare – an observation made by Burkitt 30
years ago (Burkitt, 1971), although there seems to have been
something of an increase in incidence in both sexes since the
1950s and early 1960s, but little evidence of any recent change.
The reported rates of liver cancer in Uganda have remained low
in comparison with other parts of sub-Saharan Africa although of
course much higher than in Western populations. The reasons for
this are not apparent. The prevalence of chronic carriage of
hepatitis B in Uganda is similar to that in other countries, and afla-
toxin contamination of foodstuffs appears to be common (Sebunya
and Yourtee, 1990), though less perhaps in Kampala than in other
parts of the country (Alpert et al, 1971).
The incidence rates of both breast and cervix cancer have
approximately doubled between the 1950s and 1960s, and the
1990s. The reasons for these changes are not immediately clear.
They are unlikely to be related to the epidemic of AIDS for,
although cervix cancer is considered to be an AIDS-defining
condition in the US, the evidence of a link between infection with
HIV and the risk of invasive cervical cancer is not consistent. The
role of oncogenic human papillomaviruses (HPV) in the aetiology
of cervix cancer is clearly established (IARC, 1995). HPV was
found to be present in the great majority of cervix cancers in
Uganda, with HPV type 16 in 53% (Bosch et al, 1995). It seems
quite plausible that the social disruption of the Amin dictatorship
and following civil wars (1972–1986) had favoured the spread of
HPV, like other sexually transmitted diseases. As far as breast
cancer is concerned, it is possible that some of the increase is
related to declines in fertility. Census data suggest that urban
dwellers, and those with higher educational levels, have lower
than average fertility, but it is unlikely that changes in these para-
meters could explain a doubling of incidence rates. Screening
programmes for these cancers are virtually non-existent and can
hardly have influenced trends. There has been virtually no change
in the incidence of other female cancers – corpus uteri, ovary and
vulva/vagina.
In men, the incidence of cancer of the prostate has increased
remarkably, from an age-standardized rate of 3–6 per 105 in the
1950s/60s, to 40 per 105 in the late 1990s. This is one of the
highest incidence rates recorded in Africa (Ferlay et al, 1998).
Most of this increase is in elderly men – aged 65 or over –
although the actual rates are not exceptionally high, compared
with those reported in Europe and North America. The increase in
Uganda is certainly not due to screening, although it is quite likely
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tomy for urinary symptoms in elderly men, and histological exam-
ination of operative biopsies have played a role. The level of
histological confirmation of diagnosis has actually increased over
time (Table 3) in contrast to virtually all other sites.
In contrast to prostate cancer, the incidence of penile cancer in
men is lower in the 1990s than in the 1960s (although the rates
remain high – the age-standardized rate of 3–4 in Kampala, can be
compared with 0.8 in the black population in the US SEER
registries (Parkin et al, 1997)). Penile cancer was clearly very
frequent in the early case series from Kampala (Davies et al,
1964), and Dodge et al (1973) found it ‘the commonest tumour
registered in males’ in 1964–1968. This decline in incidence is
probably real, since penile cancer is easily diagnosed and probably
always brought for medical attention. Penile cancer has been
related to genital hygiene (Kyalwazi, 1966) and the decline in inci-
dence may be related to improved hygiene as a consequence of
urbanization and greater availability of piped water supplies.
Bladder cancer is also significantly lower in the 1990s than in
the 1960s. In Uganda, bladder cancer has been linked to the pres-
ence of urethral stricture. Dodge (1964) found 30% of bladder
cancer causes had such strictures, and Owor (1975) found 4% of
patients with strictures developed bladder cancer. Since strictures
are a sequel to gonococcal infection, it is possible that better treat-
ment for STDs may have reduced their prevalence. Bladder cancer
is also a consequence of infection with Schistosoma haematobium
(IARC, 1994). However, in Uganda Schistosoma haematobium
has a rather restricted range and Kyadondo County is not among
the endemic areas (Bradley et al, 1967).
CONCLUSIONS
This long time series shows clearly the development of the
problem of cancer in modern sub-Saharan Africa. New problems
are emerging in the shape of AIDS-related cancers (KS, NHL,
conjunctival neoplasms), and cancers associated with
Westernization of lifestyles (breast and prostate cancers in partic-
ular, large bowel cancers less certainly). At the same time, there
has been little, if any, decline in the major cancers of this region –
cervix, liver and oesophagus. So far, Uganda, as most of the
region, has been spared the epidemic of tobacco-related cancer
that has been such an important feature of the cancer profile in
economically developed countries. This reprieve is probably only
temporary, however, and, while economic hardship may limit
tobacco consumption and its health consequences, it will also
restrict the capacity to mount effective programmes of cancer
control.
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